Deep vein thrombosis

What is Deep Vein Thrombosis?

Deep vein thrombosis, often shortened to DVT, is a condition in which a blood clot forms inside a deep vein, most commonly in the lower leg, thigh, or pelvis.¹ These deep veins are different from the superficial veins visible under the skin. They sit within the muscles and carry a large volume of blood back to the heart, which means a clot forming there can seriously disrupt circulation and, in some cases, break loose and travel elsewhere in the body.¹

DVT is one half of a broader condition known as venous thromboembolism, or VTE. The other half is pulmonary embolism, which occurs when a piece of a deep vein clot detaches and lodges in the lungs.² Together, DVT and PE affect as many as 900,000 people in the United States every year, and an estimated 60,000 to 100,000 Americans die from VTE annually, making it one of the leading causes of preventable death in hospitalized patients.²

A clot in a deep vein does not always announce itself. About half of people with DVT experience no noticeable symptoms at all, which is part of what makes the condition so dangerous. Silent clots can grow undetected until they cause a complication, so understanding risk factors and warning signs matters for anyone at elevated risk.¹

DVT can develop in almost anyone, but certain circumstances make clot formation far more likely. Long periods of immobility, recent surgery, certain cancers, pregnancy, and inherited clotting disorders all raise the likelihood that blood will pool and clot within a vein rather than flow smoothly back toward the heart.³

DVT and PE together comprise the most common preventable cause of hospital related death.
National Center for Biotechnology Information

Symptoms

The classic signs of DVT appear in the affected limb and typically include swelling, pain or tenderness (often starting in the calf), a feeling of warmth in the area, and skin that appears red or discolored compared to the surrounding tissue. Some people also notice that surface veins near the skin become more visible or distended.³

Because roughly half of all cases produce no symptoms whatsoever, clinicians often rely on risk assessment tools alongside imaging to identify DVT in patients who have known risk factors but no obvious complaints.³ When symptoms do appear, they are frequently mistaken for a muscle strain or minor injury, which can delay diagnosis and treatment.

Sudden shortness of breath, chest pain that worsens with a deep breath, rapid heart rate, lightheadedness, or coughing up blood are signs that a clot may have already traveled to the lungs as a pulmonary embolism. These symptoms represent a medical emergency and require immediate evaluation.⁴

Causes

Blood clots form in deep veins for one of three general reasons: slowed or pooled blood flow, damage to the vein wall, or a tendency of the blood itself to clot more easily than normal. Clinicians sometimes refer to these three contributing factors together as Virchow’s triad, and DVT formation typically begins near the valves of the calf veins, where blood flow is naturally slower and oxygen levels are lower, conditions that favor clot formation.¹

Vein damage can result from surgery, trauma, or the placement of a catheter, all of which can injure the vessel wall and trigger the clotting cascade.³ Reduced blood flow often stems from extended immobility, such as bed rest after an operation, a cast that limits movement, or sitting for hours during a long flight or car ride.³

Certain health conditions and treatments also raise the chance that blood will clot more readily. Cancer and its treatments, hormone based medications such as combined oral contraceptives, pregnancy and the weeks following delivery, and inherited clotting disorders all fall into this category.³

Risk Factors

Age plays a meaningful role, with risk climbing steadily after age 60, though DVT can occur at any age.³ A personal or family history of blood clots also substantially increases the likelihood of a future clot, particularly when an inherited clotting disorder runs in the family.

Several inherited conditions raise clotting tendency, including deficiencies of antithrombin, protein C, or protein S, the Factor V Leiden mutation, and having a blood type other than type O.³ These genetic factors do not guarantee a clot will form, but they lower the threshold at which other risk factors, such as surgery or prolonged sitting, can trigger one.

Recent major surgery, especially orthopedic procedures involving the hip or knee, is one of the strongest known triggers for DVT.² Other contributors include obesity, smoking, pregnancy, hormone therapy, cancer and chemotherapy, autoimmune conditions such as antiphospholipid syndrome, and extended travel or hospitalization that keeps a person still for many hours at a time.³

Complications

The most serious complication of DVT is pulmonary embolism, which occurs when part or all of a clot breaks free and travels through the bloodstream to the lungs, where it can block one or more pulmonary arteries.² A large PE can be fatal within minutes, which is why sudden breathing difficulty in someone with known or suspected DVT is treated as an emergency.

Even when a clot does not travel, it can cause lasting damage to the affected vein. Post thrombotic syndrome develops in as many as 60 percent of people after a DVT and can include chronic leg pain, persistent swelling, skin discoloration, and, in more severe cases, ulcers or open sores on the lower leg.² This condition can significantly affect quality of life for years after the initial clot has resolved.

Recurrence is also a real concern. Between 10 and 30 percent of people who survive an initial episode of VTE go on to develop another clot within five years, which is why many patients remain on preventive therapy well beyond their first treatment course.²

Treatment

Anticoagulant medication, commonly called a blood thinner, is the cornerstone of DVT treatment. These medications do not dissolve an existing clot but prevent it from growing larger and reduce the risk that new clots will form while the body’s own processes gradually break down the existing one.⁵

Traditional anticoagulation began with injectable heparin, transitioning to oral vitamin K antagonists such as warfarin for longer term management. Newer direct oral anticoagulants, including the factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, along with the direct thrombin inhibitor dabigatran, have largely simplified treatment by removing the need for frequent blood monitoring that older medications required.⁵

For patients who cannot tolerate anticoagulants or who have a contraindication to them, an inferior vena cava filter may be placed. This small device sits in the body’s largest vein and is designed to catch clot fragments before they can reach the lungs. Filters may be permanent or temporary, with temporary devices sometimes used alongside thrombolytic medication to help dissolve a clot before the filter is removed.⁵

In select cases involving large or limb threatening clots, physicians may use thrombolytic drugs delivered directly through a catheter, or mechanical thrombectomy devices that physically remove clot material. Compression stockings are also frequently recommended to reduce swelling and lower the risk of post thrombotic syndrome during recovery.⁴

Prevention

Preventing DVT starts with recognizing situations that slow blood flow and taking steps to keep circulation moving. During long flights or car trips, standing, walking, or flexing the calf muscles periodically helps prevent blood from pooling in the legs. Staying well hydrated also supports healthy circulation.⁴

In hospital and surgical settings, prevention becomes a structured process. Mechanical approaches, such as compression devices that intermittently squeeze the legs, work alongside chemical prophylaxis using low dose anticoagulants for patients at elevated risk.⁶ Studies suggest that as many as 70 percent of healthcare associated VTE cases could be prevented if these proven strategies were applied consistently across every hospital admission.⁷

For people with known risk factors, such as a prior clot, an inherited clotting disorder, or an upcoming surgery, working with a physician to develop an individualized prevention plan is essential. Early mobilization after surgery, maintaining a healthy weight, and staying active are protective measures within nearly everyone’s control.⁶

Why Visual Communication Matters for Deep Vein Thrombosis

Deep vein thrombosis is difficult to picture. It develops inside a vein, hidden from view, and its most dangerous complication, pulmonary embolism, happens even further out of sight inside the lungs. For patients trying to understand why a swollen calf could become life threatening, or why a small filter placed in a major vein can prevent a fatal event, clear visuals bridge a gap that words alone often cannot.¹

Clinicians, medical device companies, and patient education teams all rely on accurate visual storytelling to explain how a clot forms, how it can travel, and how each treatment option intervenes at a different point in that process. A well designed illustration or animation can turn an abstract, invisible process into something a patient can immediately grasp and act on.

• Illustrating how Virchow’s triad, slowed flow, vessel injury, and increased clotting tendency, work together to form a clot
• Showing how a clot can detach and travel from a leg vein to the lungs during a pulmonary embolism
• Demonstrating how anticoagulants, thrombolytics, and mechanical devices each act on the clotting process
• Visualizing the placement and function of an inferior vena cava filter
• Supporting patient education materials that explain risk factors and prevention strategies in accessible terms
• Creating training content for clinical staff on VTE prevention protocols

How Biotic Artlab Supports Deep Vein Thrombosis Communication

Our team works with medical device companies, healthcare systems, and life sciences organizations to translate the biology of venous thromboembolism into visuals that are both scientifically accurate and genuinely easy to understand. Whether the goal is training clinical staff, supporting a device submission, or helping patients understand their diagnosis, we build content that fits the audience and the purpose.

• Custom 3D animations depicting clot formation and embolization
• Detailed medical illustrations of venous anatomy and clotting mechanisms
• Device mechanism of action animations for anticoagulants, filters, and thrombectomy systems
• Patient facing educational materials on risk factors, symptoms, and prevention
• Clinical training content for hospital VTE prevention programs
• Conference presentations and marketing visuals for vascular and hematology audiences

Frequently Asked Questions

How is deep vein thrombosis diagnosed?

Diagnosis usually begins with a physical exam and a review of symptoms and risk factors, followed by an ultrasound of the affected limb to visualize blood flow and detect a clot. A blood test called D dimer may also be used, since elevated levels can indicate the presence of abnormal clotting activity, though this test alone cannot confirm DVT.³

Can deep vein thrombosis go away on its own?

Small clots are sometimes reabsorbed by the body over time, but DVT should never be left untreated on the assumption that it will resolve without intervention. Without treatment, a clot can grow larger or break loose and travel to the lungs, so any suspected DVT warrants prompt medical evaluation.¹

How long does treatment for DVT usually last?

Most patients take anticoagulant medication for at least three to six months, though the exact duration depends on what caused the clot and whether risk factors are ongoing. People with an inherited clotting disorder or a history of recurrent clots may need treatment for much longer, sometimes indefinitely.⁵

What is the difference between DVT and a pulmonary embolism?

DVT refers to a clot located within a deep vein, most often in the leg. A pulmonary embolism occurs when part of that clot breaks away and travels through the bloodstream to the lungs, where it blocks blood flow. PE is considered a complication of DVT and is a medical emergency.²

Who is most at risk for developing DVT?

People recovering from major surgery, those who are immobile for extended periods, individuals with cancer or inherited clotting disorders, pregnant women, and older adults face the highest risk. Combinations of these factors, such as an older adult recovering from hip surgery, further increase the likelihood of a clot forming.³

Can flying really cause deep vein thrombosis?

Sitting still for several hours during a long flight can slow circulation in the legs enough to contribute to clot formation, particularly in travelers who already have other risk factors. Moving periodically, staying hydrated, and, for higher risk travelers, wearing compression stockings can reduce this risk.⁴

Have a Project in Mind? Contact Us.

If you are developing educational content, training materials, or marketing visuals related to venous thromboembolism, our team can help bring the science to life with accuracy and clarity. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Heart, Lung, and Blood Institute. Deep Vein Thrombosis.
2. National Center for Biotechnology Information. Deep Vein Thrombosis and Pulmonary Embolism: Prevention, Management, and Anaesthetic Considerations.
3. National Heart, Lung, and Blood Institute. Venous Thromboembolism, Causes and Risk Factors.
4. American Heart Association. Venous Thromboembolism.
5. National Center for Biotechnology Information. A Review of Inferior Vena Cava Filters.
6. Johns Hopkins Armstrong Institute. Preventing Venous Thromboembolism.
7. Centers for Disease Control and Prevention. Venous Thromboembolism (Blood Clots).

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.